Supriya Srinivasan

Urolithin A, a Novel Natural Compound to Target PI3K/AKT/mTOR Pathway in Pancreatic Cancer

Tulasigeri M. Totiger, Supriya Srinivasan, Venkatakrishna R. Jala et al. · Molecular Cancer Therapeutics · 2018 · 116 citations · Full text

Comparing cellular uptake and cytotoxicity of targeted drug carriers in cancer cell lines with different drug resistance mechanisms

Tingjun Lei, Supriya Srinivasan, Yuan Tang et al. · Nanomedicine Nanotechnology Biology and Medicine · 2010 · 94 citations

Drug Resistance Analysis, Cancer Cell Lines, Drug Targeting +12

Simultaneous Delivery of Chemotherapeutic and Thermal-Optical Agents to Cancer Cells by a Polymeric (PLGA) Nanocarrier: An In Vitro Study

Yuan Tang, Tingjun Lei, Romila Manchanda et al. · Pharmaceutical Research · 2010 · 87 citations

Nanomedicine, Engineering, Therapeutic Nanomaterials +8

Mutant G protein α subunit activated by Gβγ: A model for receptor activation?

Philippe Rondard, Taroh Iiri, Supriya Srinivasan et al. · Proceedings of the National Academy of Sciences · 2001 · 78 citations · Full text

Near-infrared fluorescing IR820-chitosan conjugate for multifunctional cancer theranostic applications

Supriya Srinivasan, Romila Manchanda, Alicia Fernandez-Fernandez et al. · Journal of Photochemistry and Photobiology B Biology · 2012 · 59 citations

Nanomedicine, Polymer-drug Conjugate, Tumor Targeting +2